Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.11.21
关于全资子公司使用自有资金对CANTEX举行投资的通告
2014.11.21
第三届董事会第六次聚会决议通告
2014.11.20
2014年第四次暂时股东大会决议通告
2014.11.20
2014年第四次暂时股东大会的执法意见书
2014.11.04
关于公司使用自有资金对TPG BIOTECHNOLOGY PARTNERS IV,L.P.举行投资的通告
2014.11.04
第三届董事会第五次聚会决议通告
2014.10.30
关于会计政策变换的通告
2014.10.30
第三届董事会第四次聚会决议通告
2014.10.30
第三届监事会第四次聚会决议通告
2014.10.30
关于增添自有资金购置银行保本理工业品额度的通告
第一页
上一页
106
107
108
109
110
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】